Years back, Accera completed clinical trials to show how diet can increase ketone levels to improve Alzheimer’s. Now, this subsidiary of Nestle Foods is creating
DRUG DEVELOPMENT: The breakthrough trial of aducanumab for Alzheimer’s recently made headline news. The FDA’s Fast Track program speeds up the development of new treatments
MAJOR ADVANCE – VIDEO & ARTICLE: A new experimental drug called “aducanumab” significantly slowed memory, thinking and cognitive decline in Alzheimer’s. It works by almost
DRUG TRIAL VIDEO & ARTICLE: See how the investigational new drug, T3D-959, elicited rapid improvement in cognitive tests in 53% of subjects with Alzheimer’s. Look
VIDEO – TODAY SHOW: The 3-year A4-Trial is using solanezumab to slow memory loss caused by Alzheimer’s. See how this government-sponsored nationwide trial is making
HEALTH RESEARCH VIDEO + ARTICLE: Can a retinal-scan at an early age predict future development of Alzheimer’s? Can you use that prediction to lessen your
VIDEO + ARTICLE: Aducanumab for Alzheimer’s is showing encouraging results as Phase 3 trials roll out. See how this new immunotherapy is treating Alzheimer’s at
VIDEO + ARTICLE: In an effort to educate potential volunteers to try RVT-101 in a clinical trial, the MINDSET STUDY is trying something new. Doctors
Axovant launches nelotanserin and 3 new clinical programs to treat Lewy body dementia. Also, their drug RVT-101 for Dementia with Lewy Bodies and Alzheimer’s gets
CLINICAL TRIAL: In Alzheimer’s trials, Leuprolide (an FDA approved cancer drug) stabilized memory loss for a full year. This is the first time any therapy
Here’s Teddy Mac and his son Simon singing Oklahoma – one of his showstoppers – from a few years ago.
This isn’t any ordinary garden! It’s home to a very special group of people living well with Alzheimer’s.
The Housing Learning and Improvement Network looks at the design process and philosophy behind creating a successful Extra Care scheme.
What are the early symptoms of Alzheimer’s? When to get a professional evaluation.
SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
No spam, only news and updates.
